Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Syra HealthSYRA -9.82%12 Cash Ratio is 1.78 as of Jun. 2026, which is 5% below its 10-year median of 1.87. GuruFocus rates SYRA with a GF Score™ of 12/100 and a GF Value™ of $0.24 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 666 Healthcare Providers & Services companies, Syra Health ranks better than 77.93% on this metric.
The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.
The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.
In general, the higher the cash ratio, the better the company's liquidity position.
Syra Health Cash Ratio Related Terms
Syra Health Cash Ratio Historical Data
* Premium members only.
The historical data trend for Syra Health's Cash Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Syra Health's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Syra Health Cash Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Syra Health's Cash Ratio distribution charts can be found below:
* The bar in red indicates where Syra Health's Cash Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Syra Health (SYRA) has a Cash Ratio of 1.78 as of Jun. 2026. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Syra Health and its competitors. This is near median its historical median of 1.87. Over the past decade, Syra Health's Cash Ratio has ranged from 0.01 to 3.90. According to the industry distribution chart, Syra Health ranks #147 out of 666 companies in the Healthcare Providers & Services industry, placing it in the top 22.1%.
Is Syra Health's Cash Ratio too high?
Syra Health's current Cash Ratio of 1.78 is near median its 10-year median of 1.87. Over the past 10 years, this metric has ranged from a low of 0.01 to a high of 3.90. The Healthcare Providers & Services industry median Cash Ratio is 0.58. Syra Health's value of 1.78 is 206.9% above this industry median. Based on the distribution chart, Syra Health ranks #147 out of 666 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Syra Health has a GF Score™ of 12/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Syra Health's Cash Ratio compare to AMS and BMGL?
According to the Healthcare Providers & Services industry distribution chart, Syra Health ranks #147 out of 666 companies for Cash Ratio. This places Syra Health in the top 22% of its industry — outperforming the majority of peers. The industry median Cash Ratio is 0.58. Syra Health's value of 1.78 is 206.9% above this benchmark. Historically, Syra Health's own Cash Ratio has ranged from 0.01 to 3.90 over the past decade. While the company's 10-year median is 1.87 vs. the industry median of 0.58, Syra Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Ratio for a Healthcare Providers & Services company?
The median Cash Ratio among Healthcare Providers & Services companies is 0.58, based on 666 companies in the industry. Companies in the top quartile (top 25%) have a Cash Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cash Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Syra Health's current Cash Ratio of 1.78 is 206.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Ratio mean?
A high Cash Ratio can signal that a stock is expensive relative to its fundamentals. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Syra Health and its competitors. For the Healthcare Providers & Services industry, the median Cash Ratio is 0.58 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Syra Health's current Cash Ratio is 1.78, which is near median its own 10-year median of 1.87. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Syra Health stock overvalued right now?
Based on GuruFocus' analysis, Syra Health (SYRA) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.24, compared to a current price of $0.90 — trading 275% above its estimated fair value. The current Cash Ratio is 1.78, which is near median its 10-year median of 1.87 and 206.9% above the Healthcare Providers & Services industry median of 0.58. Syra Health's overall GF Score™ is 12/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Ratio calculated?
Cash Ratio is calculated from a company's financial statements. For Syra Health (SYRA), the current Cash Ratio is 1.78 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Syra Health (SYRA) Overvalued in 2026?
Based on GuruFocus' analysis, Syra Health stock appears to be overvalued.
The current stock price of $0.90 is trading 275% above its estimated GF Value™ of $0.24.
GuruFocus considers Syra Health to be Significantly Overvalued.
Key valuation signals for SYRA:
Cash Ratio: 1.78 (near median its 10-year median of 1.87)
GF Value™: $0.24 vs. price of $0.90 (275% above fair value)
Industry Position: 206.9% above the Healthcare Providers & Services median (#147 of 666)
No single metric tells the full story. See the SYRA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Syra Health Corp is an integrated healthcare solutions company serving government and commercial healthcare organizations. It delivers end-to-end capabilities across population health, behavioral and mental health, digital health, health education and training, and healthcare workforce development and staffing. The various services offered by the company include Syrenity, a mental health application providing preventative care and interventions for behavioral and mental health conditions; SyraBot, a chatbot offering members access to necessary information via the firm's AI-powered customer support chat system; CarePlus, an electronic medical records solution designed for small to mid-sized healthcare organizations; and patient engagement and education services, among others.
12GF Score
Get the complete analysis for SYRA
Cash Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SYRA has been successfully added to your 
